{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:24:18Z","timestamp":1791563058233,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1067\/mjd.2000.109282","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:20:13Z","timestamp":1027556413000},"page":"991-1000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Prognostic value of Ki-67 expression in localized cutaneous malignant melanoma"],"prefix":"10.1067","volume":"43","author":[{"given":"Rui","family":"Henrique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Bento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Domingues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2000.109282_bib1","first-page":"195","article-title":"Malignant melanoma: perspectives on incidence and its effects on awareness, diagnosis and treatment","volume":"46","author":"Rigel","year":"1996","journal-title":"CA Cancer J Clin"},{"key":"10.1067\/mjd.2000.109282_bib2","first-page":"5","article-title":"Cancer statistics, 1997","volume":"47","author":"Parker","year":"1997","journal-title":"CA Cancer J Clin"},{"key":"10.1067\/mjd.2000.109282_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000658-197812000-00004","article-title":"A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's methods","volume":"188","author":"Balch","year":"1978","journal-title":"Ann Surg"},{"key":"10.1067\/mjd.2000.109282_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00000658-198201001-00006","article-title":"Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm)","volume":"195","author":"Day","year":"1982","journal-title":"Ann Surg"},{"key":"10.1067\/mjd.2000.109282_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0560.1982.tb01044.x","article-title":"The nature of melanoma: a critical review","volume":"9","author":"McGovern","year":"1982","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2000.109282_bib6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/1097-0142(19891001)64:7<1432::AID-CNCR2820640712>3.0.CO;2-M","article-title":"Tumor thickness and prognosis in clinical stage I malignant melanoma","volume":"64","author":"Karakousis","year":"1989","journal-title":"Cancer"},{"key":"10.1067\/mjd.2000.109282_bib7","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, cross-sectional area, and depth of invasion in the prognosis of cutaneous melanoma","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"key":"10.1067\/mjd.2000.109282_bib8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/bjc.1992.373","article-title":"The prognosis of primary and metastasising melanoma: an evaluation of the TNM classification in 2,495 patients","volume":"66","author":"Haffner","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1067\/mjd.2000.109282_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02071520","article-title":"Predicting survival and recurrence in localized melanoma: a multivariate approach","volume":"16","author":"Soong","year":"1992","journal-title":"World J Surg"},{"key":"10.1067\/mjd.2000.109282_bib10","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/1097-0142(19950515)75:10<2499::AID-CNCR2820751016>3.0.CO;2-8","article-title":"Primary cutaneous melanoma: optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification","volume":"75","author":"Buttner","year":"1995","journal-title":"Cancer"},{"key":"10.1067\/mjd.2000.109282_bib11","first-page":"4729","article-title":"Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer","volume":"47","author":"Hedley","year":"1985","journal-title":"Cancer Res"},{"key":"10.1067\/mjd.2000.109282_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/path.1711540305","article-title":"The prognostic value of Ki67 immunostaining in non-Hodgkins lymphoma","volume":"154","author":"Hall","year":"1988","journal-title":"J Pathol"},{"key":"10.1067\/mjd.2000.109282_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-8140(89)90113-8","article-title":"Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival","volume":"15","author":"Tubiana","year":"1989","journal-title":"Radiother Oncol"},{"key":"10.1067\/mjd.2000.109282_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hon.2900020406","article-title":"Growth fractions in malignant non-Hodgkin's lymphomas as determined in situ with the monoclonal antibody Ki-67","volume":"2","author":"Gerdes","year":"1984","journal-title":"Haematol Oncol"},{"key":"10.1067\/mjd.2000.109282_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2141.1987.tb06853.x","article-title":"Immunohistochemical determination of growth fractions in human permanent cell lines and lymphoid tumors: a critical comparison of the monoclonal antibodies OKT9 and Ki-67","volume":"65","author":"Pileri","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1067\/mjd.2000.109282_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-4827(88)90350-3","article-title":"Cell cycle-dependent reactivity with the monoclonal antibody Ki 67 during myeloid cell proliferation","volume":"179","author":"Wersto","year":"1988","journal-title":"Exp Cell Res"},{"key":"10.1067\/mjd.2000.109282_bib17","first-page":"25","article-title":"Quantification and topographical description of Ki-67 antibody labelling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumour cell lines (MCF-7)","volume":"1","author":"Guillaud","year":"1989","journal-title":"Anal Cell Pathol"},{"key":"10.1067\/mjd.2000.109282_bib18","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0344-0338(11)81070-8","article-title":"Computer simulation analysis of morphological patterns in human melanocytic skin tumors","volume":"187","author":"Smolle","year":"1991","journal-title":"Pathol Res Pract"},{"key":"10.1067\/mjd.2000.109282_bib19","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/1097-0142(19871201)60:11<2797::AID-CNCR2820601133>3.0.CO;2-B","article-title":"Cell kinetics as a prognostic tool in patients with metastatic malignant melanoma of the skin","volume":"60","author":"Costa","year":"1987","journal-title":"Cancer"},{"key":"10.1067\/mjd.2000.109282_bib20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/1523-1747.ep12485060","article-title":"Ki67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions","volume":"95","author":"Moretti","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2000.109282_bib21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1600-0560.1991.tb01234.x","article-title":"Ki 67 immunostaining in melanocytic skin tumours: correlation with histologic parameters","volume":"18","author":"Soyer","year":"1991","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2000.109282_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/path.1711680104","article-title":"Mitotic indices, anti-PCNA immunostaining and AgNORs in thick cutaneous melanomas displaying paradoxical behaviour","volume":"168","author":"Evans","year":"1992","journal-title":"J Pathol"},{"key":"10.1067\/mjd.2000.109282_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/1523-1747.ep12312431","article-title":"MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous malignant melanoma","volume":"105","author":"Ramsey","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2000.109282_bib24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0190-9622(96)90607-6","article-title":"MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma","volume":"35","author":"Boni","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109282_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1365-2559.1996.d01-558.x","article-title":"p53 protein and Ki-67 expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin","volume":"30","author":"Vogt","year":"1997","journal-title":"Histopathology"},{"key":"10.1067\/mjd.2000.109282_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00008390-199806000-00013","article-title":"Prognostic value of biomarkers in malignant melanoma","volume":"8","author":"Hernberg","year":"1998","journal-title":"Melanoma Res"},{"key":"10.1067\/mjd.2000.109282_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-0560.1992.tb01351.x","article-title":"Prognostic significance of proliferation and motility in primary malignant melanoma of the skin","volume":"19","author":"Smolle","year":"1992","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2000.109282_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0560.1993.tb00648.x","article-title":"Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions: a quantitative immunohistochemical study","volume":"20","author":"Rieger","year":"1993","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2000.109282_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0560.1995.tb00746.x","article-title":"Cell proliferation markers in predicting metastases in malignant melanoma","volume":"22","author":"Reddy","year":"1995","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2000.109282_bib30","first-page":"705","article-title":"The histogenesis and biologic behavior of primary human malignant melanomas of the skin","volume":"29","author":"Clark","year":"1969","journal-title":"Cancer Res"},{"key":"10.1067\/mjd.2000.109282_bib31","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archderm.1978.01640180005001","article-title":"Prognostic index in malignant melanoma","volume":"114","author":"Schmoeckel","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.109282_bib32","first-page":"163","article-title":"Malignant melanoma of the skin","author":"American Joint Committee on Cancer","year":"1997"},{"key":"10.1067\/mjd.2000.109282_bib33","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/1097-0142(19870315)59:6<1236::AID-CNCR2820590634>3.0.CO;2-I","article-title":"Prognostic index for malignant melanoma","volume":"59","author":"Kopf","year":"1987","journal-title":"Cancer"},{"key":"10.1067\/mjd.2000.109282_bib34","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumour progression","volume":"81","author":"Clark","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1067\/mjd.2000.109282_bib35","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ijc.2910430303","article-title":"Pathologic prognostic factors for cutaneous malignant melanoma: the Western Canada Melanoma Study","volume":"43","author":"Worth","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1067\/mjd.2000.109282_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000658-198804000-00014","article-title":"Prognostic significance of DNA aneuploidy in Stage I cutaneous melanoma","volume":"207","author":"Kheir","year":"1988","journal-title":"Ann Surg"},{"key":"10.1067\/mjd.2000.109282_bib37","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0046-8177(86)80417-8","article-title":"Mitosis counts: reproducibility and significance in grading of malignancy","volume":"17","author":"Donhuijsen","year":"1986","journal-title":"Hum Pathol"},{"key":"10.1067\/mjd.2000.109282_bib38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/jcp.43.7.597","article-title":"Does delay in fixation affect the number of mitotic figures in processed tissue?","volume":"43","author":"Cross","year":"1990","journal-title":"J Clin Pathol"},{"key":"10.1067\/mjd.2000.109282_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/path.1711600202","article-title":"The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables","volume":"160","author":"Quinn","year":"1990","journal-title":"J Pathol"},{"key":"10.1067\/mjd.2000.109282_bib40","first-page":"200","article-title":"A computerized mathematical model and scoring system for predicting outcome in melanoma patients","author":"Soong","year":"1992"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200358972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200358972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:25:14Z","timestamp":1759267514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962200358972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S0190962200358972"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2000.109282","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of Ki-67 expression in localized cutaneous malignant melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mjd.2000.109282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}